IBD Patients Safely Received Live Vaccines
A study found no adverse infections in patients who took live vaccines while on immune-modifying drugs.
Updated on Oct. 13, 2026 in COVID-19
Live Poll
Do you feel reassured by the recent findings regarding accidental live vaccinations for immunocompromised patients?
Researchers reported that 220 IBD patients who inadvertently received live vaccines while on immunosuppressive therapies experienced no viral infections within 30 days. This finding challenges current safety protocols that typically advise against live vaccinations for immunocompromised individuals.
Why it matters
Live vaccines are generally contraindicated for those on immune-modifying drugs due to concerns that an impaired immune system cannot control the weakened virus. Understanding the true risk profile is vital for improving vaccination coverage in patients with inflammatory bowel disease.
The study followed 220 IBD patients for 30 days to monitor for measles, mumps, rubella, chickenpox, or shingles after accidental exposure. No infections were detected, and hospitalization rates were statistically similar to a control group receiving non-live vaccines.
The players
American College of Gastroenterology
This is a professional medical association dedicated to the clinical practice of gastroenterology and the advancement of research in the field.
Centers for Disease Control and Prevention
The CDC is the leading national public health institute of the United States tasked with protecting public health and safety.
The details
The study, presented as abstract P1120, tracked patients who received MMR, varicella, or MMRV vaccines while undergoing immunosuppressive treatment. While the results suggest safety in this cohort, the findings remain preliminary and have not been reviewed by the broader scientific community.
Timeline
October 8, 2026, marked the date the CDC recorded 4,080 confirmed measles cases in the U.S.
October 2026 saw the presentation of these research findings at the American College of Gastroenterology annual meeting.
Health Landscape
This research complicates long-standing clinical guidelines regarding vaccine contraindications for immunocompromised patients. It suggests a potential shift in how medical professionals approach immunization schedules for patients on immune-modifying therapies.
Patients currently on immunosuppressive therapy should continue to consult their gastroenterologist before receiving any vaccinations. This study suggests that future clinical protocols may evolve, potentially expanding access to immunizations for those with chronic inflammatory conditions.
The takeaway
While these findings are encouraging, they represent preliminary data that has not yet been subjected to the rigor of peer review. Patients should not alter their vaccination plans without direct guidance from their treating physician.
Further reading
For more on vaccination guidelines and disease prevention, visit the COVID-19 section.
Source note: This article includes information reported by Medical Daily.
Live Poll
Do you feel reassured by the recent findings regarding accidental live vaccinations for immunocompromised patients?
